top of page
Disease modeling through the Extracellular Matrix (ECM)
What is PathECM?
7
3
Partnering Institutions in a consortium aimed at using physics to develop the drug discovery models of tomorrow.
Independent disease models, starting wth our endometriosis model, EndoECM
4
100
Drugs in the pipeline as a result of PathECM
Patients participating in the study to help us better define ground truth.
PathECM is a project aimed at elucidating the important components of tissue driven disease, incorporating them into 3D human tissue models and creating next generation therapeutics that treat root causes.
Our Team
Get to know us
Prof Kristian FranzeÂ
Project Lead, FAU Erlangen
kristian.franze@fau.de
Prof Ewa Paluch
University of Cambridge
Dr Joe SwiftÂ
University of Manchester
Dr Alex EckersleyÂ
University of Manchester
Dr. Vianney Delplace
Nantes University
Dr. Léa Wenger
Cyclana Bio
Prof. Kevin Chalut
Cyclana Bio
Dr. Stéphane Petres
Institut Pasteur
bottom of page